Showing 1351-1360 of 2094 results for "".
Sneak Peek: CSF Returns to Nashville
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2021/sneak-peek-csf-returns-to-nashville/23617/Next month’s live meeting covers a range of hot topics in dermatology.Histiocytoses: A Review of the Most Recent Classification System
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histiocytoses-a-review-of-the-most-recent-classification-system/20503/A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.The Skin Microbiome: Commensal Bacteria Impact Human Health
https://practicaldermatology.com/issues/supplements/the-skin-microbiome-commensal-bacteria-impact-human-health/23246/Close Up With Emma Guttman-Yassky, MD, PhD
https://practicaldermatology.com/topics/close-up/close-up-with-emma-guttman-yassky-md-phd/23953/Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.How Much Are You Leaving on the Table?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-leaving-on-the-table/21444/How to improve your after-tax financial efficiency for 2014.Clinical Insights and Emerging Therapeutic Options for Chronic Hand Eczema
https://practicaldermatology.com/issues/october-2025/clinical-insights-and-emerging-therapeutic-options-for-chronic-hand-eczema/39763/Chronic hand eczema (CHE) represents a significant clinical challenge in dermatology practice, affecting approximately 5% of the population—a prevalence approximately twice that of psoriasis.Therapeutics Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/theraputics-update/20492/New products and pharmacologic developmentsDermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of